Workflow
6月3日投资早报|比亚迪5月新能源汽车销量38.25万辆,绿通科技拟收购大摩半导体不低于51%股权,今日一只新股申购
Xin Lang Cai Jing·2025-06-03 00:36

Market Performance - On May 30, 2025, A-shares saw a collective decline with the Shanghai Composite Index down 0.47% closing at 3347.49 points, the Shenzhen Component Index down 0.85% at 10040.63 points, and the ChiNext Index down 0.96% at 1993.19 points. The total trading volume decreased by 462.43 billion yuan compared to the previous trading day, totaling 11391.79 billion yuan [1] - On June 2, 2025, Hong Kong stocks also experienced a downturn, with the Hang Seng Index falling 0.57% to 23157.97 points, and the total trading volume at 1452.45 billion HKD [1] - In contrast, U.S. stocks closed higher on June 1, 2025, with the Dow Jones up 0.08% at 42,305.48 points, the S&P 500 up 0.41% at 5,935.94 points, and the Nasdaq up 0.67% at 19,242.61 points [1] New Stock Offering - Haiyang Technology, with stock code 603382, is offering shares at a price of 11.5 yuan per share and a price-to-earnings ratio of 12.69. The company is a major player in the R&D, production, and sales of Nylon 6 series products, including Nylon 6 chips, Nylon 6 yarn, and tire cord fabric [3] Industry News - The Ministry of Industry and Information Technology (MIIT) of China announced an increase in efforts to regulate "involutionary" competition in the automotive industry, supporting the initiative from the China Association of Automobile Manufacturers to maintain a fair and orderly market environment [4] - In May 2025, China's Manufacturing Purchasing Managers' Index (PMI) was reported at 49.5%, an increase of 0.5 percentage points from the previous month, indicating a slight recovery in manufacturing activity. The production index rose to 50.7%, suggesting an acceleration in production activities [5] - Various regions in China are implementing measures to prevent the illegal outflow of strategic minerals, with specific actions taken by provinces like Guizhou, Hunan, and Guangxi to enhance regulatory compliance and oversight [6] Emerging Opportunities - The clinical enrollment for implantable brain-machine interface technology has officially started, providing hope for millions of spinal cord injury patients. This initiative is led by Huashan Hospital and Xuanwu Hospital, aiming to validate the effectiveness and safety of the treatment [6]